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ORIGINAL RESEARCH
Preoperative Right Ventricular Free- Wall 
Longitudinal Strain as a Prognosticator 
in Isolated Surgery for Severe Functional 
Tricuspid Regurgitation
Minkwan Kim , MD, PhD*; Hyun- Jung Lee, MD*; Jun- Bean Park , MD, PhD; Jihoon Kim, MD;  
Seung- Pyo Lee , MD, PhD; Yong- Jin Kim, MD, PhD; Sung- A Chang , MD, PhD; Hyung- Kwan Kim , MD, PhD
BACKGROUND: Severe tricuspid regurgitation (TR) should be intervened before the development of irreversible right ventricular 
(RV) dysfunction. However, current guidelines do not provide criterion related to RV systolic function to guide optimal surgi-
cal timing. We investigated the prognostic value of RV longitudinal strain in patients undergoing isolated surgery for severe 
functional TR.
METHODS AND RESULTS: We enrolled 115 consecutive patients (aged 62±10 years; 23.5% men; 62.6% [n=72] with previous left- 
sided valve surgery) who underwent isolated surgery for severe functional TR at 2 tertiary centers. Preoperative clinical and 
echocardiographic parameters, including RV free- wall longitudinal strain (RVFWSL), were collected. The primary end point 
was a composite of cardiac death and unplanned readmission attributable to cardiovascular causes 5 years after surgery. 
Forty patients (34.8%) reached the primary end point during 333 person- years of follow- up. There were 11 cardiac deaths and 
34 unplanned readmissions attributable to cardiovascular causes, with 5 patients experiencing both. An absolute preopera-
tive RVFWSL <24% was associated with the primary end point (hazard ratio, 2.30; 95% CI, 1.22– 4.36; P=0.011), independent 
of clinical risk factors, including European System for Cardiac Operative Risk Evaluation II and hemoglobin levels. Meanwhile, 
other conventional echocardiographic measures of RV systolic function were not significant. The addition of an absolute 
RVFWSL <24% provided incremental prognostic value to the clinical model for predicting the primary end point.
CONCLUSIONS: Preoperative RVFWSL as an indicator of RV dysfunction was an independent prognosticator in patients under-
going isolated surgery for severe functional TR. Thus, preoperative RVFWSL could help determine the optimal surgical timing 
for severe functional TR.
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Severe functional tricuspid regurgitation (TR) is increasingly recognized in patients who under-went successful prior left- sided valve surgery or 
those with long- standing atrial fibrillation.1 Increasing 
TR severity is associated with higher morbidity and 
mortality irrespective of pulmonary hypertension 
and right ventricular (RV) or left ventricular (LV) dys-
function.2 Sustained severe TR results in RV systolic 
dysfunction, which is accepted as an independent 
predictor of clinical outcomes in patients undergoing 
corrective TR surgery.1,3– 5 A vicious circle of severe 
TR, RV volume overload, tricuspid annular dilatation, 
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and resultant TR aggravation is a pathophysiologi-
cal pathway leading to a poor TR- associated prog-
nosis.1,5 Although timely correction of severe TR has 
been shown to improve functional capacity, hemody-
namics, and clinical outcomes,4,6– 8 delaying surgery 
may result in persistent RV dysfunction,9 even with 
percutaneous or surgical correction of severe TR, 
and subsequently lead to venous congestion, organ 
damage, and poor clinical outcomes, similar to those 
observed in mitral regurgitation.1,3– 5,8 Previous stud-
ies have consistently demonstrated that RV systolic 
function is an important determinant of postoperative 
outcomes.1,3– 6,8,10 Although preoperative conventional 
echocardiography- based RV assessments have been 
used,4,7 echocardiographic assessment of RV systolic 
function has long been clinically challenging and tech-
nically difficult because of the complex geometry of the 
RV.
Myocardial strain measurement using speckle 
tracking echocardiography is a well- established and 
reproducible method that is used to reflect the systolic 
function of the ventricles. Preoperative LV global lon-
gitudinal strain was recently shown to be helpful for 
predicting postoperative outcomes and may guide 
the optimal surgical timing in patients with severe mi-
tral regurgitation.11,12 Although prognostic value of the 
RV longitudinal strain was demonstrated in patients 
with ischemic heart disease13 and pulmonary hyper-
tension,14 it is unclear if RV longitudinal strain plays an 
important role in patients with severe isolated func-
tional TR requiring surgical correction. Therefore, the 
purpose of this study was to investigate the prognostic 
value of RV longitudinal strain and its ability to predict 
the clinical outcomes of patients undergoing isolated 
surgery for severe functional TR.
METHODS
The data that support the findings of this study are 
available from the corresponding author on reason-
able request.
Study Subjects
Between January 2005 and April 2019, consecu-
tive patients undergoing isolated corrective surgery 
for severe functional TR were prospectively enrolled 
from 2 tertiary centers. We systematically excluded 
patients with primary TR based on imaging, surgi-
cal, and/or pathological findings. All patients satisfied 
the following criteria for severe TR on preoperative 
echocardiography4– 6,15– 17: (1) a TR jet area >30% of 
the right atrial area, (2) vena contracta width >7 mm, 
and (3) systolic flow reversal in the hepatic veins. 
Patients who underwent index echocardiography be-
fore 2005 were excluded because digitized echocar-
diographic images were unavailable (n=23). We also 
excluded patients with severe TR secondary to LV 
failure with reduced ejection fraction (defined as LV 
ejection fraction ≤45%) or severe pulmonary hyper-
tension (defined as systolic pulmonary artery pres-
sure ≥70 mm Hg),18,19 and those with coronary artery 
disease that required intervention based on preopera-
tive coronary angiography. Only patients with isolated 
severe functional TR as a single hemodynamically 
significant lesion were included, and patients with 
significant left- sided valve disease necessitating con-
comitant surgical correction were excluded. A total of 
115 patients with severe isolated functional TR were 
included in the final analysis. The study protocol was 
approved by the institutional review boards of both 
centers. Informed consent was waived because of 
the retrospective nature of the study.
Data Collection and Outcomes
Clinical data, including the preoperative and postop-
erative New York Heart Association (NYHA) functional 
CLINICAL PERSPECTIVE
What Is New?
• Preoperative right ventricular free- wall longi-
tudinal strain is an independent predictor of 
postoperative outcomes and showed an incre-
mental prognostic value over clinical variables in 
patients undergoing isolated surgery for severe 
functional tricuspid regurgitation.
What Are the Clinical Implications?
• Preoperative right ventricular longitudinal strain 
could be a useful imaging surrogate marker for 
clinical outcome and could suggest optimal 
surgical timing for severe functional tricuspid 
regurgitation.
Nonstandard Abbreviations and Acronyms
EuroSCORE European System for Cardiac 
Operative Risk Evaluation
NYHA New York Heart Association
RV4CSL right ventricular 4- chamber strain 
(including the ventricular septum)
RV- ESA right ventricular end- systolic area
RV- FAC right ventricular fractional area 
change
RVFWSL right ventricular free- wall 
longitudinal strain
TR tricuspid regurgitation
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class, were collected. Preoperative blood test re-
sults were obtained, and the glomerular filtration rate 
was estimated using the Chronic Kidney Disease– 
Epidemiology Collaboration equation. Cardiac opera-
tive risk was estimated using European System for 
Cardiac Operative Risk Evaluation (EuroSCORE) II.20
The index date was defined as the day when TR 
surgery was performed. Echocardiography was per-
formed a median of 12 days (interquartile range [IQR], 
4– 39 days) before the surgery. The primary end 
point was a composite of major postoperative car-
diac events, which was defined by cardiac death or 
unplanned readmission attributable to cardiovascular 
causes within 5  years. Data on all- cause death and 
cardiac death during the postoperative follow- up were 
collected. Operative mortality, defined as death within 
30 days of the surgery or before hospital discharge, 
was assessed separately. Unplanned readmission at-
tributable to cardiovascular causes was defined as re-
admission attributable to heart failure, coronary artery 
disease, stroke, infective endocarditis at the repaired 
or prosthetic tricuspid valve (TV), or arrhythmia.
Patients were followed up until they reached the 
primary end point, were lost to follow- up or death, 
or until 5  years after surgery. Outcomes were as-
sessed by thorough review of medical records, and 
mortality was confirmed using the nationwide official 
data on death certification provided by the National 
Statistical Office of Korea. Telephone interviews 
were systematically performed in a blinded manner 
by one trained research nurse to monitor the devel-
opment of clinical events in patients who did not re-
turn to the clinic.
Conventional Echocardiography
Comprehensive echocardiographic examination 
was performed before surgery in all patients with 
commercially available equipment (General Electric 
Healthcare, Milwaukee, WI; Philips, Bothell, WA; and 
Siemens, Erlangen, Germany). LV end- systolic/end- 
diastolic dimensions, LV end- diastolic interventricu-
lar septal/posterior wall thickness, and LV ejection 
fraction were measured according to the guide-
lines.21 The vena contracta width was measured at 
the narrowest portion of the tricuspid regurgitant jet 
from the zoomed apical 4- chamber view.16 RV end- 
diastolic area and RV end- systolic area (RV- ESA) 
were obtained in the RV- focused apical 4- chamber 
view, and RV fractional area change (RV- FAC) was 
calculated as 100×(RV end- diastolic area−RV- ESA)/
RV end- diastolic area.21 Pulmonary artery systolic 
pressure was estimated from the peak TR velocity 
using the Bernoulli equation, 4v2+right atrial pres-
sure.22 The maximum diameter of the inferior vena 
cava and its respiratory variation were measured at 1 
to 2 cm from the junction with the right atrium in the 
subcostal view. The percentage decrease in the infe-
rior vena cava diameter was used to estimate mean 
right atrial pressure.21,22 Echocardiographic meas-
urements were averaged for 3 consecutive heart 
beats in sinus rhythm and for 5 in atrial fibrillation.
RV Longitudinal Strain Measurement
All digitized echocardiographic images were sent 
to a core laboratory, and RV longitudinal strain was 
measured using vendor- independent 2- dimensional 
Cardiac Performance Analysis software (TomTec 
Imaging System, Munich, Germany) by one experi-
enced sonographer blinded to patient clinical infor-
mation. In brief, the endocardial border of the RV 
was manually traced on the end- systolic frame in an 
RV- focused apical 4- chamber view, with end systole 
defined as the smallest RV volume observed dur-
ing the cardiac cycle. The software tracks speckles 
along the RV endocardial border and myocardium 
throughout the cardiac cycle.23 RV free- wall longi-
tudinal strain (RVFWSL) was calculated at the RV 
free wall, which was used as the main measure for 
RV longitudinal strain, according to the guidelines.24 
Also, RV 4- chamber strain (including the ventricu-
lar septum) (RV4CSL) was calculated at the total RV 
wall that includes the ventricular septum and RV free 
wall. Because longitudinal strain values are nega-
tive by definition, we used absolute values for a sim-
pler comparison throughout the article, with “lower” 
or “worse” values denoting smaller absolute strain 
values.
Measurement Reproducibility
Intraobserver and interobserver variabilities for 
RVFWSL and RV4CSL measurements were assessed 
in 30 randomly selected patients. To determine in-
traobserver variability, the same observer, who was 
blinded to the former results, repeated RVFWSL and 
RV4CSL measurements for each selected patient at a 
separate time point. To determine interobserver varia-
bility, another experienced sonographer independently 
measured RVFWSL and RV4CSL while blinded to the 
previous results.
Statistical Analysis
Continuous variables were presented as mean±SD, 
or as median (IQR) if normality assumption was re-
jected by the Shapiro- Wilk test. Categorical vari-
ables were presented as numbers and percentages. 
Comparisons of continuous data were made using 
the Student t test or Mann- Whitney U test. Categorical 
data were compared using the χ2 test or the Fisher 
exact test. For statistical comparison, NYHA class 
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was divided into 2 groups (NYHA class I and II ver-
sus NYHA class III and IV) and compared before and 
after surgery using the McNemar test. To ascertain 
the optimal cutoff value of RVFWSL and RV4CSL for 
the clinical end point, receiver operating character-
istic curve analysis was performed on the basis of 
the Youden index,25 and was confirmed using spline 
regression curves. Kaplan- Meier survival curves for 
the study end point, according to the RVFWSL and 
RV4CSL cutoff values, were constructed and com-
pared using the log- rank test. After checking the 
proportional hazards assumption, Cox regression 
analyses were performed to assess predictors of 
the study end point. EuroSCORE II and other signifi-
cant clinical variables on univariate Cox regression 
were incorporated into the multivariable models. The 
predictive value of echocardiographic parameters 
of RV systolic function, including RV- ESA, RV- FAC, 
RVFWSL, and RV4CSL, were assessed with mul-
tivariable adjustment for clinical variables. Because 
they are physiologically associated with one another, 
the RV- ESA, RV- FAC, and RV longitudinal strain val-
ues were not simultaneously entered into the same 
multivariable model. The incremental values of RV 
echocardiographic parameters for predicting the pri-
mary end point were assessed by exploring changes 
in the global χ2 values in the sequentially constructed 
multivariable models, starting with the clinical model, 
including EuroSCORE II and hemoglobin levels. The 
performance of each survival model was statistically 
compared using net reclassification improvement and 
integrated discrimination improvement. All P values 
were 2 sided, and P<0.05 was considered statistically 
significant. All statistical analyses were performed 
using R version 3.6.1 software (R Development Core 
Team, Vienna, Austria) with “rcompanion," “pROC,” 
“survminer,” and “survNRI” packages.
RESULTS
Baseline Characteristics
Of 115 patients (mean age, 62.3±9.9  years), 88 
(76.5%) were women. Seventy- two patients (62.6%) 
had previously undergone valve surgery; 16 of these 
had previously undergone concomitant tricuspid an-
nuloplasty. The mean length of time between the 
operations was 17.0±6.3  years. For the index TR 
surgery, 84 patients (73.0%) received tricuspid valve 
replacement, whereas 31 (27.0%) received tricuspid 
valve repair. Combined maze operation was per-
formed in 40 patients (34.8%).
Patients were followed up for 5  years after the 
index TR surgery, and 40 patients (34.8%) reached 
the primary end point during 333 person- years of fol-
low- up. There were 11 cardiac deaths and 34 cases of 
unplanned readmission attributable to cardiovascular 
causes. Five patients experienced both hospitalization 
and cardiac death, in whom the first event (ie, hospital-
ization) was included in the primary end point analysis.
There were no significant differences in age, sex, 
traditional cardiovascular risk factors, atrial fibrillation, 
previous cardiac surgery and its type, and the index 
TR surgery type between patients who did and did 
not reach the primary end point (Table  1). However, 
patients reaching the primary end point had a lower 
hemoglobin level, lower estimated glomerular filtration 
rate, and higher EuroSCORE II.
Echocardiographic parameters are summarized 
in Table  2. Patients who reached the primary end 
point tended to have worse RV longitudinal strain val-
ues compared with those who did not (24.8% versus 
26.5% for RVFWSL [P=0.051]; 21.8% versus 23.6% for 
RV4CSL [P=0.051]). The RV- FAC, RV- ESA, vena con-
tracta width, LV ejection fraction, and pulmonary pres-
sures were not different between the groups (Table 2).
Outcomes
All- cause and cardiac mortality during the follow-
 up were 14.8% (n=17) and 9.6% (n=11), respectively. 
Specific causes of cardiac death included heart failure 
in 6 patients, documented ventricular fibrillation in 1 pa-
tient, and sudden cardiac death in 4 patients. Causes 
of noncardiac death included postoperative hypoxic 
brain damage, subdural hematoma, and infection. 
Operative mortality was 5.2% (n=6); 4 of these patients 
experienced cardiac death, but no patient died dur-
ing the surgery. Unplanned readmission attributable to 
cardiovascular causes was attributable to heart failure 
in 23 patients, stroke in 4 patients, infective endocardi-
tis in 1 patient, and arrhythmia in 6 patients.
The median lengths of intensive care unit and hos-
pital stay were 5 days (IQR, 2.0– 6.5 days) and 22 days 
(IQR, 15.0– 31.5 days), respectively.
The NYHA functional class 6  months after dis-
charge was available in 108 patients, excluding those 
who died within 6 months (n=7). Significant improve-
ments in the functional capacity were observed after 
surgery (Figure 1); ie, the proportion of NYHA class III/
IV was dramatically decreased after TR surgery (from 
48.7% [n=56] to 4.6% [n=5]). More specifically, the 
NYHA class improved in 88.0% (n=95), remained the 
same in 10.2% (n=11), and worsened in 1.8% (n=2). 
Postoperatively, only 5 patients (4.6%) had NYHA class 
III dyspnea, whereas the rest (95.4%) had NYHA class 
I or II dyspnea (Figure S1).
Prognostic Impact of RV Longitudinal 
Strain
The best cutoff value with the highest Youden 
index on the receiver operating characteristic curve 
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Table 1. Baseline Clinical Characteristics, According to the Primary End Point
Characteristic
Primary End Point (+)  
(n=40)
Primary End Point (−)  
(n=75) P Value
Demographics
Age, y 63.4±9.9 61.8±9.9 0.421
Female sex 28 (70.0) 60 (80.0) 0.330
Body mass index, kg/m2 22.0±3.6 23.2±3.2 0.083
Preoperative NYHA functional class 0.106
Class I 2 (5.0) 1 (1.3)
Class II 14 (35.0) 42 (56.0)
Class III 22 (55.0) 31 (41.3)
Class IV 2 (5.0) 1 (1.3)
Cardiovascular risk factors
EuroSCORE II, % 3.7 (2.5– 5.5) 3.2 (1.6– 4.0) 0.028
Hypertension 8 (20.0) 20 (26.7) 0.572
Diabetes mellitus 8 (20.0) 11 (14.7) 0.638
Chronic kidney disease 3 (7.5) 5 (6.7) 0.999
Previous stroke 0 (0.0) 4 (5.3) 0.341
Atrial fibrillation 31 (77.5) 68 (90.7) 0.097
Previous cardiac surgery 29 (72.5) 43 (57.3) 0.162
Mitral valve surgery 27 (67.5) 45 (60.0) 0.556
Aortic valve surgery 10 (25.0) 15 (20.0) 0.703
Tricuspid annuloplasty 7 (17.5) 9 (12.0) 0.597
Maze operation 3 (7.5) 2 (2.7) 0.465
Type of index TR surgery 0.752
Tricuspid valve replacement 28 (70.0) 56 (74.7)
Mechanical valve 5 (12.5) 14 (18.7)
Bioprosthetic valve 23 (57.5) 42 (56.0)
Tricuspid valve repair 12 (30.0) 19 (25.3)
Combined Maze operation 12 (30.0) 28 (37.3) 0.561
Major laboratory findings
Hemoglobin, g/dL 12.0±1.9 12.6±1.5 0.049
Platelet, ×106/mL 152.5 (106.5– 209.0) 147.0 (107.5– 191.0) 0.653
Total protein, mg/dL 7.3 (6.6– 7.6) 7.0 (6.3– 7.7) 0.448
Albumin, mg/dL 4.1 (3.6– 4.4) 4.1 (3.6– 4.4) 0.895
Total cholesterol, mg/dL 138.0 (116.0– 172.0) 154.0 (138.5– 173.0) 0.145
GFR, mL/min per 1.73 m2 65.6 (49.4– 78.2) 74.2 (64.9– 85.5) 0.011
Preoperative medications
Antiplatelet 4 (10.0) 6 (8.0) 0.988
RAS blocker 7 (25.9) 20 (74.1) 0.382
β- Blocker 2 (5.0) 15 (20.0) 0.060
Aldosterone receptor blocker 20 (50.0) 42 (56.0) 0.676
Loop diuretics 26 (65.0) 49 (65.3) 0.999
Digoxin 17 (42.5) 37 (49.3) 0.615
Amiodarone 2 (5.0) 7 (9.3) 0.646
Anticoagulant 24 (60.0) 50 (66.7) 0.612
Categorical variables are presented as the number (percentage). Continuous variables are presented as mean±SD or median (interquartile range), as 
appropriate. EuroSCORE indicates European System for Cardiac Operative Risk Evaluation; GFR, estimated glomerular filtration rate (by Chronic Kidney 
Disease– Epidemiology Collaboration equation); NYHA, New York Heart Association; RAS, renin- angiotensin system; and TR, tricuspid regurgitation.
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was 24% (sensitivity, 52.5%; specificity, 75.7%) for 
RVFWSL and 21% (sensitivity, 50.0%; specific-
ity, 77.0%) for RV4CSL. Spline regression curves 
confirmed that these cutoff values were associated 
with an increased risk of reaching the primary out-
come (Figure S2).
Table 2. Baseline Echocardiographic Parameters, According to the Primary End Point
Parameter
Primary End Point (+)  
(n=40)
Primary End Point (−)  
(n=75) P Value
RV end- diastolic area, cm2 30.6±6.9 30.2±6.8 0.787
RV end- systolic area, cm2 17.3±4.6 17.0±4.1 0.763
RV fractional area change, % 43.2±9.2 43.0±9.6 0.889
Tricuspid annulus diameter, mm 48.0 (42.0– 55.0) 48.0 (41.5– 53.0) 0.526
LV end- systolic dimension, mm 31.0 (27.5– 34.0) 32.0 (27.0– 35.0) 0.853
LV end- diastolic dimension, mm 47.8±6.8 46.9±7.3 0.536
LV ejection fraction, % 56.4±7.7 58.1±7.2 0.253
Estimated PA systolic pressure, mm Hg 38.0 (32.5– 42.0) 36.0 (32.0– 41.0) 0.531
IVC diameter
Expiratory, mm 26.9±5.5 26.1±6.2 0.513
Collapse, % 66.6 (52.7– 75.5) 66.7 (54.4– 77.8) 0.810
Vena contracta width, mm 9.4 (8.6– 11.5) 10.4 (8.4– 11.6) 0.487
RVFWSL, % 24.8±5.0 26.5±4.3 0.051
RV4CSL, % 21.8±4.9 23.6±4.3 0.051
Continuous variables are presented as mean±SD or median (interquartile range), as appropriate. IVC indicates inferior vena cava; LV, left ventricular; PA, 
pulmonary artery; RV, right ventricular; RV4CSL, RV 4- chamber strain (including the ventricular septum); and RVFWSL, RV free- wall longitudinal strain.
Figure 1. Changes in the New York Heart Association (NYHA) functional class in patients 
who completed the 6- month clinical follow- up.
For statistical analysis, patients were divided into 2 groups (ie, NYHA class I and II vs NYHA class 
III and IV). *Using the McNemar test.
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Kaplan- Meier event- free survival curves showed 
significant differences in the primary end point, with 
the RVFWSL cutoff of 24% and the RV4CSL cutoff of 
21% (Figure  2). Event- free survival curves started to 
separate during the early postoperative period and 
continued to diverge throughout the follow- up.
Univariate Cox regression analysis with clinical 
and echocardiographic parameters is shown in 
Table S1. The cutoff values of RV- ESA ≥20 cm2 and 
RV- FAC <35% were selected according to the pre-
vious study.4 Univariate analysis revealed that higher 
EuroSCORE II, lower estimated glomerular filtration 
rate, lower hemoglobin levels, higher NYHA class, 
and worse RVFWSL and RV4CSL were significantly 
associated with the primary end point, whereas RV- 
ESA, RV- FAC, LV ejection fraction, and pulmonary 
artery systolic pressure were not. In the multivari-
able analysis, the model 1 was constructed using 
significant clinical factors on univariable analysis (ie, 
the EuroSCORE II and hemoglobin level). Thereafter, 
analyses were performed by serially adding echo-
cardiographic parameters reflecting RV systolic 
function to model 1 (Table 3). RV- ESA and RV- FAC 
were not associated with the primary end point in 
multivariable analysis (models 2 and 3 in Table  3, 
respectively). RVFWSL <24%, however, was inde-
pendently associated with the primary end point in 
multivariable analysis (model 4) (hazard ratio [HR], 
2.30; 95% CI, 1.22– 4.36; P=0.011). In addition, 
RV4CSL <21% was independently associated with 
the primary end point (model 5) (HR, 2.36; 95% CI, 
1.25– 4.47; P=0.008).
Incremental Value of RV Longitudinal 
Strain for Predicting Clinical Events
The incremental value of RV longitudinal strain to pre-
dict the primary end point over clinical risk factors 
was assessed by sequential Cox analysis (Figure  3). 
Compared with the clinical model (model 1), adding 
RV- ESA or RV- FAC did not significantly increase the 
global χ2 values. However, adding RVFWSL or RV4CSL 
significantly improved the global χ2 values (P=0.012 
and P=0.010, respectively). The addition of RVFWSL 
to model 1 also increased the C- statistic (from 0.619 
to 0.692) and showed incremental predictive value for 
the primary end point with a positive overall continuous 
net reclassification index of 0.52 (95% CI, 0.16– 0.89; 
P=0.005) and a positive integrated discrimination index 
of 0.060 (95% CI, 0.016– 0.105; P=0.008). Similar data 
were observed for RV4CSL (Table 4).
Measurement Reproducibility
Analysis of intraobserver variability of the RV longi-
tudinal strain measurement revealed excellent cor-
relations between the repeated measurements. 
Intraclass correlation coefficients for RVFWSL and 
RV4CSL were 0.98 (95% CI, 0.96– 0.99) and 0.94 
(95% CI, 0.89– 0.97), respectively. There was also a 
good correlation between the measurements by 2 
independent observers for interobserver variability; 
intraclass correlation coefficients for RVFWSL and 
RV4CSL were 0.88 (95% CI, 0.78– 0.93) and 0.90 
(95% CI, 0.82– 0.95), respectively. Bland- Altman 
plots for interobserver and intraobserver variabilities 
Figure 2. Kaplan- Meier survival curves for the primary end point, according to the right ventricular (RV) longitudinal strain.
The primary end point of cardiac death or unplanned readmission attributable to cardiovascular causes according to RV free- wall 
longitudinal strain (RVFWSL) cutoff value of 24% (A) and RV 4- chamber strain (including the ventricular septum) (RV4CSL) cutoff value 
of 21% (B).
(a) (b)
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of RVFWSL and RV4CSL measurement are shown in 
Figures S3 and S4.
DISCUSSION
The present study is the first to demonstrate the prog-
nostic value of preoperative RV longitudinal strain 
in patients undergoing isolated surgery for severe 
functional TR. The main findings are summarized as 
follows. First, isolated surgery for severe functional 
TR resulted in significant improvement in functional 
capacity (of at least one grade) in 95 patients (88%). 
However, the operative mortality was still high (5.2%), 
and the 5- year all- cause and cardiac mortality rates 
could not be ignored (14.8% and 9.6%, respectively). 
Second, preoperative RV longitudinal strain was inde-
pendently associated with the primary end point after 
Table 3. Multivariable Cox Models for the Prediction of the Primary End Point, Including RV Parameters
Variables
Model 1*
Model 2  
(Model 1+RV- ESA)
Model 3  
(Model 1+RV- FAC)
HR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value
EuroSCORE II 1.14 (1.00– 1.31) 0.046 1.14 (1.00– 1.30) 0.045 1.14 (0.99– 1.31) 0.056
Hemoglobin, g/dL 0.90 (0.82– 0.99) 0.035 0.90 (0.82– 1.00) 0.040 0.90 (0.82– 0.99) 0.035
RV- ESA ≥20 cm2 1.13 (0.53– 2.41) 0.750
RV- FAC <35% 1.07 (0.46– 2.49) 0.884
Variables
Model 4 (Model 1+RVFLSW) Model 5 (Model 1+RV4CSL)
HR (95% CI) P Value HR (95% CI) P Value
EuroSCORE II 1.09 (0.94– 1.26) 0.251 1.09 (0.94– 1.26) 0.238
Hemoglobin, g/dL 0.84 (0.69– 1.01) 0.062 0.83 (0.69– 1.00) 0.053
RVFWSL <24% 2.30 (1.22– 4.36) 0.011
RV4CSL <21% 2.36 (1.25– 4.47) 0.008
EuroSCORE indicates European System for Cardiac Operative Risk Evaluation; HR, hazard ratio; RV, right ventricular; RV4CSL, RV 4- chamber strain 
(including the ventricular septum); RV- ESA, RV end- systolic area; RV- FAC, RV fractional area change; and RVFWSL, RV free- wall longitudinal strain.
*Multivariable clinical model includes EuroSCORE II and other significant clinical variables on univariate analysis. For each multivariable model 2 to 5, 
echocardiographic parameters of RV function were added to the model 1.
Figure 3. Incremental value of the right ventricular (RV) longitudinal strain over clinical variables 
for predicting the primary end point by global χ2 changes in sequential Cox analysis.
The clinical model included European System for Cardiac Operative Risk Evaluation and hemoglobin 
level. RV4CSL indicates RV 4- chamber strain (including the ventricular septum); RV- ESA, RV end- systolic 
area; RV- FAC, RV fractional area change; and RVFWSL, RV free- wall longitudinal strain.
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adjusting for clinical variables and showed an incre-
mental prognostic value over clinical variables for the 
primary end point. These findings suggest that preop-
erative RV longitudinal strain could be a useful imaging 
marker for optimizing the timing of isolated surgery for 
severe functional TR.
Prognosticators of Isolated TR Surgery
Although the prevalence of moderate or greater TR is 
higher than previously thought and on the rise, only 
2.6% of these patients receive corrective surgery.26 
Isolated surgery for significant TR is even less fre-
quently performed, accounting for only 20% of total 
TR surgeries.27 Taking a passive stance in isolated TR 
surgery is likely caused by concerns of high in- hospital 
mortality (8%– 10% reported) and uncertainty of long- 
term outcomes.28,29
Isolated severe TR leads to progressive RV failure 
and reduces life expectancy10; however, timely inter-
vention can induce RV reverse remodeling.6 According 
to a recent study, the median length of time from diag-
nosis to TR surgery was up to 13.5 months (IQR, 4.2– 
31.7 months) in patients undergoing isolated surgery 
for severe TR,29 suggesting delayed surgical referral. 
Survival rates may decline by delaying intervention; 
thus, it is plausible to conclude that determining the 
optimal surgical timing for isolated severe TR surgery 
before the development of RV dysfunction and end- 
organ damage is crucial for better clinical outcomes.
Previous studies have demonstrated that clini-
cal factors, such as age, male sex, liver cirrhosis, 
lower glomerular filtration rate, lower hemoglobin 
levels, and the presence of severe symptoms, like 
dyspnea, are associated with adverse outcomes 
after TR surgery.4,8,30 In addition, preoperative RV 
dimensions and systolic function, determined by 
echocardiography or cardiac magnetic resonance 
(CMR), were associated with postoperative out-
comes. Analogous to LV systolic function in patients 
with severe mitral regurgitation, RV systolic function 
in patients with severe TR seems preserved at an 
earlier stage because of favorable loading condi-
tions.4,5 Once RV systolic dysfunction is objectively 
observed on echocardiography or CMR, surgical 
interventions cannot completely reverse RV systolic 
function because of irreversible damage to the RV 
myocardium.28 However, the current guidelines do 
not recommend quantitative assessment of RV sys-
tolic function by conventional echocardiography for 
technical reasons.31 Recently, the LV global longitu-
dinal strain showed some promising data for guiding 
surgical referral in patients with severe mitral regur-
gitation.11,12 A similar concept could be applied to 
RV longitudinal strain in patients with TR. We herein 
demonstrated that RVFWSL, with a cutoff of 24%, 
can predict long- term postoperative outcomes and 
aid in optimizing the timing of isolated surgery for 
severe functional TR (Figure  4). Furthermore, the 
separation of event- free survival curves began from 
the early postoperative period, emphasizing the 
role of RV longitudinal strain as an early and late 
prognosticator.
RV Longitudinal Strain for Measuring RV 
Systolic Function and Its Prognostic Value
RV longitudinal strain has some advantages over con-
ventional echocardiographic indexes for RV systolic 
function. First, RV longitudinal strain is measured by 
tracking the location of speckles on sequential im-
ages; thus, it is angle independent.32 Second, as dem-
onstrated in the present study, RV longitudinal strain 
showed an additive prognostic value over clinical vari-
ables. Third, RV longitudinal strain correlated well with 
the CMR- derived RV ejection fraction, with lower in-
terobserver and intraobserver variabilities.33 Although 
CMR is the gold standard for RV systolic function 
measurement and provides incremental prognostic in-
formation,5 CMR is an expensive modality and its use 
is limited in patients with implantable electronic de-
vices, claustrophobia, or severe dyspnea.5 However, 
Table 4. Incremental Value of RV Echocardiographic Parameters to Clinical Variables for Predicting the Primary End Point
Variable
C- Statistic Net Reclassification Index Integrated Discrimination Improvement
95% CI 95% CI
P Value for 
Difference* 95% CI
P Value for 
Difference*
Clinical model (model 1)† 0.619 (0.509– 0.728)
Clinical model†+RV- ESA ≥20 cm2 0.616 (0.506– 0.727) 0.886 0.852
Clinical model†+RV- FAC <35% 0.611 (0.501– 0.721) 0.876 0.523
Clinical model†+RVFWSL <24% 0.692 (0.582– 0.801) 0.52 (0.16– 0.89) 0.005 0.060 (0.016– 0.105) 0.008
Clinical model†+RV4CSL <21% 0.699 (0.592– 0.807) 0.55 (0.18– 0.91) 0.003 0.070 (0.021– 0.118) 0.005
RV indicates right ventricular; RV4CSL, RV 4- chamber strain (including the ventricular septum); RV- ESA, RV end- systolic area; RV- FAC, RV fractional area 
change; and RVFWSL, RV free- wall longitudinal strain.
*Compared with model 1.
†Clinical model includes European System for Cardiac Operative Risk Evaluation II and hemoglobin level.
J Am Heart Assoc. 2021;10:e019856. DOI: 10.1161/JAHA.120.019856 10
Kim et al RV Strain for Isolated Severe Functional TR Surgery
echocardiographic RV longitudinal strain can avoid 
these limitations.
A previous study by Prihadi et al34 also demon-
strated that RVFWSL was a sensitive marker of RV sys-
tolic dysfunction and had incremental prognostic value 
to RV- FAC and tricuspid annular plane systolic excur-
sion for predicting survival in patients with moderate 
to severe functional TR who were mostly followed up 
without TR surgery. To note, the RV longitudinal strain 
values in the earlier study were lower compared with 
those in the present study (mean, 14.4% versus 25.9%), 
although a similar cutoff value for RV dysfunction was 
used (RVFWSL <23%). The difference in the baseline 
characteristics of the study population may contribute. 
Specifically, the earlier study included patients with func-
tional TR of moderate or severe grade with or without 
left- sided valve disease. Those patients were older, had 
lower LV ejection fractions, and had worse RV systolic 
function. Apart from the differences in baseline char-
acteristics, different software programs used for strain 
measurement might contribute to differences in RV lon-
gitudinal strain results.
Limitations
A few limitations should be acknowledged. First, this 
was a retrospective study, and some bias may remain 
despite adjustments. Second, the sample size was rela-
tively small (n=115); this was attributable to strict inclu-
sion criteria (ie, patients undergoing “isolated” surgery for 
severe functional TR). However, this is the first study to 
investigate the decisive role of RV longitudinal strain in 
optimizing the timing of isolated surgery for severe func-
tional TR, with careful long- term follow- up in all patients. 
Third, patients without digitized echocardiographic im-
ages (n=23) were excluded, which might have intro-
duced selection bias. Fourth, there may be a concern 
Figure 4. Two representative examples.
A, A 71- year- old woman with a right ventricular free- wall longitudinal strain (RVFWSL) of 27.8% remained event free. B, A 50- year- 
old man with an RVFWSL of 21.1% was readmitted because of heart failure 3 years after surgery. RV4CSL indicates right ventricular 
4- chamber strain (including the ventricular septum). Endo indicates endocardium.
(b)
(a)
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about intervendor differences in RV longitudinal strain 
measurements.35 To avoid this issue, we used a single, 
vendor- independent, commercialized software to meas-
ure the RV longitudinal strain. Finally, the cutoff value for 
RVFWSL and RV4CSL may be variable, depending on 
population of interest and the strain analysis program 
used; external validation is thus required to confirm the 
cutoff value of the present study.
CONCLUSIONS
RVFWSL with a cutoff value of 24% is independently as-
sociated with postoperative cardiac death and unplanned 
readmission attributable to cardiovascular causes in 
patients undergoing isolated surgery for severe func-
tional TR. Impaired RV systolic function, as assessed 
by RVFWSL and RV4CSL, has incremental prognostic 
value to a clinical variables– based multivariable model. 
Incorporating preoperative RV longitudinal strain into clini-
cal practice may be helpful for predicting postoperative 
outcomes and for optimizing surgical timing in severe 
functional TR.
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HR (95% CI) P value 
Age* 1.16 (0.98–1.37) 0.085 
Male sex 1.72 (0.87–3.40) 0.121 
Body mass index, kg/m2 0.90 (0.81–1.01) 0.065 
EuroSCORE II 1.19 (1.05-1.35) 0.008 
Hypertension 0.90 (0.41–1.95) 0.783 
Diabetes mellitus 1.52 (0.70–3.33) 0.291 
Atrial fibrillation 0.50 (0.24–1.05) 0.069 
GFR† 0.89 (0.83–0.96) 0.002 
Hemoglobin, g/dL 0.77 (0.64–0.93) 0.006 
NYHA Fc, per class 1.81 (1.05-3.13) 0.034 
NYHA Fc III-IV 2.01 (1.07-3.79) 0.031 
LV ejection fraction, % 0.98 (0.94-1.02) 0.349 
PASP, mmHg 1.00 (0.96-1.04) 0.996 
RV ESA ≥20 cm2 1.31 (0.62-2.77) 0.475 
RV FAC <35% 1.24 (0.55-2.82) 0.602 
RVFWSL, % 1.07 (1.00-1.15) 0.047 
RV4CSL, % 1.07 (1.00-1.14) 0.043 
RVFWSL <24% 2.68 (1.44-5.00) 0.002 
RV4CSL <21% 2.66 (1.43-4.96) 0.002 
* per 5-year increase. † per 5 mL/min/1.73m2 increase. 
HR, hazard ratio; CI, confidence interval; NYHA Fc, New York Heart Association functional 
class; GFR, estimated glomerular filtration rate; RV, right ventricle; ESA, end-systolic area; 
FAC, fractional area change; RVFWSL, RV free wall longitudinal strain; RV4CSL, RV 4-
chamber strain including the ventricular septum. 
  
Figure S1. Changes in the NYHA functional class in patients who completed the six-
month clinical follow-up. 
 
 
Values are presented as numbers. Of 115 patients who underwent surgery for isolated severe 
functional tricuspid regurgitation, 7 died within 6 months, while 108 survived. The 
preoperative NYHA class of the 7 patients who died were class IV in one, class III in five, and 
class II in one. 
NYHA, New York Heart Association. 
  
Figure S2. Cutoff values of RVFWSL and RV4CSL for the prediction of the primary 
endpoint. 
 
RVFWSL, RV free-wall longitudinal strain; RV4CSL, RV 4-chamber strain (including the 
ventricular septum).  
Figure S3. Bland-Altman plot for comparing intra-observer variability of RV 
longitudinal strain measurement. 
 
ICC, intra-class correlation coefficient; RVFWSL, RV free-wall longitudinal strain; RV4CSL, 
RV 4-chamber strain (including the ventricular septum).  
Figure S4. Bland-Altman plot for comparing inter-observer variability of RV longitudinal 
strain measurement. 
 
ICC, intra-class correlation coefficient; RVFWSL, RV free-wall longitudinal strain; RV4CSL, 
four-chamber strain (including the ventricular septum). 
